Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
1997-2-27
|
pubmed:abstractText |
The alpha-adrenoceptor antagonist properties of doxazosin and its enantiomers were characterized using human prostate tissue and cell membranes isolated from rat-1 fibroblast expressing each of the cloned human alpha 1-adrenoceptor subtypes. In the alpha 1-adrenoceptor-binding studies on the human prostate with [3H]doxazosin and 2-{[beta-(3-[125I],4-hydroxyphenyl)ethyl]aminomethyl}-l-tetralone ([125I]HEAT), no significant differences were observed between racemic doxazosin, R-doxazosin and S-doxazosin (mean -log Ki (pKi) values were 8.60-8.63, 8.47-8.55 and 8.61-8.65, respectively), whereas the alpha 2-adrenoceptor-binding studies with [3H]rauwolscine and [3H]clonidine revealed that the alpha 2-adrenoceptor-binding affinity of S-doxazosin (pKi = 5.91-5.94) was slightly (3- or 4-fold), but significantly lower than that of R-doxazosin (pKi = 6.47-6.54). Studies in phenylephrine-contracted prostatic tissue showed no significant difference in alpha 1-adrenoceptor antagonist potency between racemic doxazosin, R-doxazosin and S-doxazosin (pA2 values were 8.43 +/- 0.28, 8.64 +/- 0.56 and 8.75 +/- 0.38, respectively). In the binding studies with cloned alpha 1-adrenoceptor subtypes using [3H]prazosin and [125I]HEAT, racemic doxazosin, R-doxazosin and S-doxazosin showed no selectivity for the alpha 1-adrenoceptor subtypes. The present study demonstrated that doxazosin and its enantiomers are highly selective alpha 1-adrenoceptor antagonists and that there is no evidence suggesting differential alpha 1-adrenoceptor antagonist effects of doxazosin and its enantiomers in the human prostate. Doxazosin, therefore, could be described as displaying balanced activity across all three alpha 1-adrenoceptor subtypes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic alpha-Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/BE 2254,
http://linkedlifedata.com/resource/pubmed/chemical/Doxazosin,
http://linkedlifedata.com/resource/pubmed/chemical/Phenethylamines,
http://linkedlifedata.com/resource/pubmed/chemical/Prazosin,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Tetralones
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0014-2999
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
10
|
pubmed:volume |
313
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
135-43
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8905340-Adrenergic alpha-Antagonists,
pubmed-meshheading:8905340-Analysis of Variance,
pubmed-meshheading:8905340-Binding, Competitive,
pubmed-meshheading:8905340-Binding Sites,
pubmed-meshheading:8905340-Cell Line,
pubmed-meshheading:8905340-Dose-Response Relationship, Drug,
pubmed-meshheading:8905340-Doxazosin,
pubmed-meshheading:8905340-Humans,
pubmed-meshheading:8905340-Male,
pubmed-meshheading:8905340-Phenethylamines,
pubmed-meshheading:8905340-Prazosin,
pubmed-meshheading:8905340-Prostate,
pubmed-meshheading:8905340-Radioligand Assay,
pubmed-meshheading:8905340-Receptors, Adrenergic, alpha,
pubmed-meshheading:8905340-Stereoisomerism,
pubmed-meshheading:8905340-Tetralones
|
pubmed:year |
1996
|
pubmed:articleTitle |
The alpha-adrenoceptor antagonist properties of the enantiomers of doxazosin in the human prostate.
|
pubmed:affiliation |
Department of Urology, New York University Medical Center, NY 10016, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|